Join
Live feed
·
PRReleasevia Quantisnow
Royalty Pharma plc logo

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

ByQuantisnow·Wall Street's wire, on your screen.
RPRX· Royalty Pharma plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc) and more on Quantisnow.